Article
Economics
Yu Liu, Shikun Wang, Liang Li, Ying Xu, Yu Shen, Ya-Chen Tina Shih
Summary: This study compares the mean cost trajectories between non-Hispanic White (NHW) and non-Hispanic Black (NHB) patients with localized prostate cancer, finding that the cost trajectories of NHB were significantly higher than those of NHW, especially for patients with higher comorbidity scores. These results suggest that the higher costs in NHB patients with high comorbidity scores may contribute to the greater healthcare-related financial burden compared to NHW patients.
Article
Oncology
Michelle Ann B. Eala, Edward Christopher Dee, Ophira Ginsburg, Melvin Lee Kiang Chua, Nirmala Bhoo-Pathy
Summary: This commentary highlights the financial toxicities linked to cancer in low- and middle-income countries, specifically in Southeast Asia. It discusses interventions at various levels that can help alleviate financial toxicity in the region and in similarly resourced parts of the world.
Review
Oncology
Elzbieta Cipora, Olga Partyka, Monika Pajewska, Aleksandra Czerw, Katarzyna Sygit, Marian Sygit, Mateusz Kaczmarski, Dominika Mekal, Edyta Krzych-Falta, Anna Jurczak, Katarzyna Karakiewicz-Krawczyk, Sylwia Wieder-Huszla, Tomasz Banas, Ewa Bandurska, Weronika Ciecko, Andrzej Deptala
Summary: According to forecasts, the incidence of pancreatic cancer is expected to increase, leading to higher costs for the healthcare system and indirect costs related to lost productivity. With the changing demographic structure in developed countries, it is crucial to keep more people of working age in the labor market. Pancreatic cancer poses a significant economic burden due to its high mortality rate and late stage diagnosis.
Article
Nutrition & Dietetics
Ignacio Ruiz-Garcia, Victoria Contreras-Bolivar, Francisco Jose Sanchez-Torralvo, Osmayda Ulloa-Diaz, Maria Ruiz-Vico, Jose Abuin-Fernandez, Manuel Barrios-Garcia, Emilio Alba-Conejo, Gabriel Olveira
Summary: This study found that the coding rate of disease-related malnutrition (DRM) is low in cancer inpatients, resulting in significant economic losses for hospitals.
CLINICAL NUTRITION
(2022)
Review
Gastroenterology & Hepatology
Alina M. Allen, Jeffrey Lazarus, Zobair M. Younossi
Summary: Non-alcoholic fatty liver disease (NAFLD) has significant health, economic and social implications, requiring a shift in conceptualization and collaborative action to address the public health threat. The healthcare costs of NAFLD patients are nearly double compared to those without the disease, with the highest costs in advanced fibrosis and end-stage liver disease. NAFLD accounts for the highest increase in disability-adjusted life years (DALYs) among all liver diseases globally. Currently, there are no specific drug therapies for NAFLD and non-alcoholic steatohepatitis (NASH), with uncertainties surrounding cost, treatment duration, and their impact on liver-related outcomes and mortality.
JOURNAL OF HEPATOLOGY
(2023)
Review
Oncology
Anca-Narcisa Neagu, Danielle Whitham, Emma Buonanno, Avalon Jenkins, Teodora Alexa-Stratulat, Bogdan Ionel Tamba, Costel C. Darie
Summary: Breast cancer is a complex and multi-faceted disease that poses a challenge for precision diagnostic and personalized oncology in the new era. Proteomics technologies play a crucial role in the discovery of diagnostic, prognostic, and predictive biomarkers for breast cancer.
AMERICAN JOURNAL OF CANCER RESEARCH
(2021)
Article
Public, Environmental & Occupational Health
Shah Alam Khan, Karla Hernandez-Villafuerte, Diego Hernandez, Michael Schlander
Summary: Breast cancer is a heterogeneous disease with a significant economic burden. Understanding the factors that affect its costs is crucial for developing effective policies. Early-stage breast cancer has lower costs compared to late-stage breast cancer. This study conducted a literature review and developed a decision tree model to estimate the stage-wise medical costs of breast cancer in Germany.
FRONTIERS IN PUBLIC HEALTH
(2023)
Article
Health Care Sciences & Services
Abolhasan Afkar, Habib Jalilian, Abolghasem Pourreza, Habibeh Mir, Abdolhosein Emami Sigaroudi, Somayeh Heydari
Summary: This study compared the costs of treating breast cancer patients in private and public hospitals in Iran. The results showed that patients in private hospitals had lower direct and indirect costs compared to those in public hospitals. The treatment of breast cancer imposes a significant economic burden on patients, insurance organizations, and society in Iran.
BMC HEALTH SERVICES RESEARCH
(2021)
Article
Medicine, General & Internal
Bryce A. Kiberd, Karthik K. Tennankore, Amanda J. Vinson
Summary: This study used a medical decision analytical model to estimate the net benefit and costs of allocating deceased donor kidneys to preemptively waitlisted patients versus those receiving dialysis. The results showed that preemptive kidney transplantation was the best option from a patient perspective, but allocating kidneys to patients receiving dialysis was a better use of scarce resources from a societal perspective.
Article
Surgery
Cameron E. Gaskill, Adam Gyedu, Barclay Stewart, Robert Quansah, Peter Donkor, Charles Mock
Summary: The research in Ghana reveals a significant unmet need for cancer surgery, with the current surgical volume only addressing a small portion of the demand, particularly lacking in therapeutic procedures. Efforts to increase cancer-specific surgical capacity are essential to meet the growing needs in LMICs.
WORLD JOURNAL OF SURGERY
(2021)
Article
Oncology
Christopher P. P. Childers, Abhineet Uppal, Matthew Tillman, George J. J. Chang, Hop S. Tran S. Cao
Summary: This study analyzed surgical cases of stage I-III colorectal cancer from 2010 to 2019 and found that the increasing use of robotic surgery is leading to disparities in access to minimally invasive surgery for colorectal cancer, especially across different patient insurance groups.
ANNALS OF SURGICAL ONCOLOGY
(2023)
Article
Oncology
Adam Fundytus, Manju Sengar, Dorothy Lombe, Wilma Hopman, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Roitberg, Elisabeth G. E. De Vries, Lorenzo Moja, Andre Ilbawi, Richard Sullivan, Christopher M. Booth
Summary: The study investigated the alignment of cancer medicines in the WHO Essential Medicines List with the priorities of frontline oncologists worldwide, as well as the accessibility of these medicines in different countries. The findings reveal significant barriers in access to core cancer medicines globally, emphasizing the urgent need for policy action to ensure patients with cancer have access to essential medicines.
Article
Medicine, General & Internal
Christoffer Bugge, Odd Terje Brustugun, Erik Magnus Saether, Ivar Sonbo Kristiansen
Summary: Valid estimates of cancer treatment costs are important for priority setting, with higher lifetime costs identified for cancers with a 5-year relative survival between 50% and 70%. Future cancer costs are highly dependent on future cancer incidence, changes in death risk, and cancer-specific unit costs. Gender- and cancer-specific estimates of treatment costs are important for assessing equity of care and understanding resource consumption.
Article
Oncology
Roxanne Garaszczuk, Jean H. E. Yong, Zhuolu Sun, Claire de Oliveira
Summary: This study estimated the economic burden of cancer in Canada from a societal perspective. The findings revealed that cancer-related costs in Canada amounted to CAD 26.2 billion in 2021, with 30% of costs being borne by patients and their families. The study also highlighted that the highest costs were incurred in the first year after cancer diagnosis, reaching almost CAD 4.8 billion in 2021.
Article
Oncology
Jean H. E. Yong, Claude Nadeau, William M. Flanagan, Andrew J. Coldman, Keiko Asakawa, Rochelle Garner, Natalie Fitzgerald, Martin J. Yaffe, Anthony B. Miller
Summary: OncoSim-Breast model is a simulation model that accurately reproduces breast cancer trends and screening effects, and it is of great importance for informing policy decisions related to early detection of breast cancer.